Genelux Corporation (GNLX)
NASDAQ: GNLX · Real-Time Price · USD
2.615
-0.045 (-1.69%)
Aug 31, 2026, 4:00 PM EDT - Market closed
Genelux Market Cap
Genelux has a market cap or net worth of $117.18 million as of August 31, 2026. Its market cap has decreased by -5.76% in one year.
Market Cap
117.18M
Enterprise Value
100.93M
1-Year Change
-5.76%
Ranking
Category
Stock Price
$2.62
ChartMarket Cap Chart
Since the IPO on January 26, 2023, Genelux's market cap has decreased from $141.69M to $117.18M, a decrease of -17.30%. That is a compound annual growth rate of -5.14%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 31, 2026 | 117.18M | -28.55% |
| Dec 31, 2025 | 164.02M | 103.78% |
| Dec 31, 2024 | 80.49M | -78.50% |
| Dec 29, 2023 | 374.31M | 164.17% |
| Jan 26, 2023 | 141.69M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Vivani Medical | 128.09M |
| Aardvark Therapeutics | 126.71M |
| Cibus | 126.11M |
| Biomea Fusion | 125.40M |
| ProMIS Neurosciences | 123.62M |
| enGene Therapeutics | 122.26M |
| Tenax Therapeutics | 122.01M |
| Anixa Biosciences | 118.40M |